Rhizoma Gastrodiae Tablets Market
Rhizoma Gastrodiae Tablets Market Analysis By Type (Gastrodia Elata F., G. Elata Bl. F.), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), & By Region - Global Insights to 2031
Analysis of Rhizoma Gastrodiae Tablets market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Key Questions Answered in Report
-
What are the growth prospects for rhizoma gastrodiae tablets market from 2021-2031?
According to Fact. MR’s analysis, demand for rhizoma gastrodiae tablets is anticipated to witness a considerable incline from 2021 to 2031 and expand at a CAGR exceeding 10%. Extensive uptake to treat chronic ailments such as liver disorders will greatly
-
Which country will generate the most promising expansion opportunities for rhizoma gastrodiae tablet manufacturers?
China is likely to emerge as the center-stage for enhanced sales of rhizoma gastrodiae tablets, expected to generate over 50% of total revenue from 2021 to 2031. Simultaneously, India is anticipated to experience a surge of 9% CAGR across the aforemention
-
Which type of rhizoma gastrodiae tablets are expected to generate maximum demand through 2031?
Fact.MR anticipates demand for gastrodia elata f. glauca rhizoma gastrodiae tablets to surge at a staggering 10% CAGR over the next ten years.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Report Also Addresses:
- Market Estimates and Forecasts (2016-2031)
- Key Drivers and Restraints Shaping Market Growth
- Segment-wise, Country-wise, and Region-wise Analysis
- Competition Mapping and Benchmarking
- Brand Share and Market Share Analysis
- Key Product Innovations and Regulatory Climate
- COVID-19 Impact on Rhizoma Gastrodiae Tablets and How to Navigate
- Recommendation on Key Winning Strategies
Demand for Rhizoma Gastrodiae Tablets from 2016 to 2020 Vs Future Market Projections for 2021-2031
From 2016 to 2020, sales of rhizoma gastrodiae tablets were significantly high, expanding at under 10% CAGR. Increasing preference for traditional and alternative medicine over conventional allopathic ones amid rising health concerns has been driving majority of market growth.
The COVID-19 pandemic has promised significant future expansion prospects, as key healthcare providers seek to incorporate natural alternatives to reduce inflammation episodes. From 2021 to 2031, demand is likely expand at a CAGR exceeding 10% as key regions incorporate plant-based medicine to address such key problems as liver diseases.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
How is Demand for Plant-based Medicine Spurring Rhizoma Gastrodiae Tablet Sales?
Traditional herbal medicines are acquiring significant attention in the global healthcare industry. Data from the World Health Organization (W.H.O) concludes that traditional herbal medicine was effectively used to treat severe acute respiratory syndrome (SARS) in China, while 80% of Africans deployed various forms of herbal medicine.
Worldwide annual market for these products is currently valued at US$ 60 billion, and it is anticipated that traditional herbal medicine will make significant strides in the global market, with countries such as China, India, Nigeria and the U.S expected to make significant strides, eventually heightening prospects for rhizoma gastrodiae tablets.
Increasing Prevalence of Liver Disorders Opening Up New Frontiers for Rhizoma Gastrodiae Tablets?
Liver disease accounts for approximately 2 million deaths annually worldwide, half of them due to complications arising out of cirrhosis and the balance as a result of viral hepatitis and hepatocellular carcinoma, according to the National Center for Biotechnology Information.
Moreover, about 2 billion people consume alcohol worldwide and upwards of 75 million are diagnosed with alcohol-use disorders and are at risk of alcohol-associated liver disease. In addition, a significant chunk of the population also lives with fatty liver. Hence, rhizoma gastrodiae tablets are likely to prove useful in mitigating these diseases, inclining their demand.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
What are the Key Challenges to Market Expansion for Manufacturers of Rhizoma Gastrodiae Tablets?
A major challenge expected to hamper sales of rhizoma gastrodiae tablets is the limited presence of adequate manufacturers. Currently, bulk of all products manufacturing is restricted to China, attributed to the presence of regional level players.
However, certain players are attempting to expand their business in overseas markets in order to expand their geographical footprint, widening expansion prospects. Another challenge is that of regulatory approvals. Due to availability of limited literature, key authorities are unable to ascertain their effectiveness, delaying product launches.
Country-wise Analysis
How is Growing Popularity of Alternative Medicine Bolstering Rhizoma Gastrodiae Tablet Sales in the U.S.?
The market for rhizoma gastrodiae tablets in the U.S is likely to expand at under 5% CAGR until 2031. Increasing preference for herbal medicines over conventional ones is largely attributed as the chief growth driver for the region.
According to the American Botanical Council, sales of herbal products exceeded US$ 5.3 billion as of the beginning of the previous decade, climbing by 8% to reach around US$ 6 billion by 2013. It further rose to over US$ 9 billion in 2019. Hence, prospects for these medicines appear highly bright across the U.S
Why is Demand for Rhizoma Gastrodiae Tablets High in China?
China is expected to remain the epicenter for global rhizoma gastrodiae tablets, generating more than 50% of the revenue share across the forecast period. Extensive development of Traditional Chinese Medicine (TCM) underpins majority of the East Asian giant’s market growth prospects.
A plethora of chronic ailments have been addressed in China by virtue of traditional herbal-based medicine. As per the World Health Organization (W.H.O), TCM accounts for around 40% of all healthcare delivered. Hence, a number of regional level manufacturers have emerged across key provinces.
How are Growth Prospects for Rhizoma Gastrodiae Tablets Surging in India?
India is poised to exhibit a robust 9% CAGR with respect to rhizoma gastrodiae tablets sales in forthcoming years. The Indian Journal of Pharmacology estimates that 60% of registered physicians are involved in traditional and alternate systems of medicine in India.
Additionally, there are about 700,000 registered practitioners of traditional medicine, majority in Ayurveda, and around 650,000 registered practitioners of modern medicine in India. Also, heightening concerns over allopathic medicines on overall health is also spurring demand for natural medicines, thus providing impetus to market growth.
Category-wise Analysis
Why are Gastrodia Elata F. Glauca Rhizoma Gastrodiae Tablets Highly Preferred?
By type, demand for gastrodia elata f. glauca rhizoma gastrodiae tablets is likely to witness an impressive incline, at a staggering 10% CAGR until 2031. These tablets have proven highly effective in addressing a variety of ailments.
Gastrodia elata. f. glauca derived rhizoma gastrodiae tablets has been used to treat conditions such as headache, dizziness, convulsion, paralysis, rheumatism, epilepsy, strokes, spasms and lumbago.
Competitive Landscape
The rhizoma gastrodiae tablets landscape appears highly consolidated, with a major chunk of it being dominated by Chinese players. Some notable developments in the market include:
- In June 2017, Beijing Tong Ren Tang Europe Holding B.V entered a strategic co-operation agreement with the Republic of Kazakhstan for establishing a Chinese Medical Center to further Chinese Medicine
- In November 2019, Tsumura & Co. concluded its Letter of Intent regarding Tianjin China Medico Technology Co. Ltd. to forge a capital alliance with the intention of expanding its business in Traditional Chinese Medicine and ensure stable supply of crude drugs
*This list is indicative- full details about prominent rhizoma gastrodiae tablets manufacturers is available upon request.
Report Scope
|
Attribute |
Details |
|
Forecast Period |
2021-2031 |
|
Historical Data Available for |
2016-2020 |
|
Market Analysis |
US$ Mn for Value & ‘000 Units for Volume |
|
Key Regions Covered |
|
|
Key Countries Covered |
|
|
Key Segments Covered |
|
|
Key Companies Profiled |
|
|
Pricing |
Available upon Request |
Key Market Segments Covered
-
Type
- Gastrodia Elata F. Glauca Rhizoma Gastrodiae Tablets
- G. Elata Bl. F. Elta Rhizoma Gastrodiae Tablets
- Other Rhizoma Gastrodiae Tablets
-
Distribution Channel
- Rhizoma Gastrodiae Tablets for Hospital Pharmacies
- Rhizoma Gastrodiae Tablets for Retail Pharmacies
- Rhizoma Gastrodiae Tablets for Online Pharmacies
-
Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Spain
- Italy
- Rest of Europe
- East Asia
- China
- Japan
- South Korea
- Rest of East Asia
- South Asia
- India
- ASEAN
- Rest of South Asia
- Middle East & Africa
- GCC
- South Africa
- Rest of MEA
- Oceania
- Australia & New Zealand
- Rest of Oceania
- North America
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions/Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product modifications /Innovation 4. Key Success Factors 4.1. Strategic Developments 4.2. Key regulations 4.3. Product USPs /Technology 4.4. List of manufacturers and providers 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP outlook 5.1.2. Increasing R&D Expenditure 5.2. Forecast Factors - Relevance & Impact 5.2.1. New product launches 5.2.2. Cost of products 5.2.3. Increasing adoption of Rhizoma Gastrodiae Tablets 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. COVID19 Crisis Analysis 6.1.1. Current COVID19 Statistics and Probable Future Impact 6.1.2. Current GDP Projection and Probable Impact 6.1.3. Current Economic Projection as compared to 2008 Economic analysis 6.1.4. COVID19 and Impact Analysis 6.1.4.1. Revenue By Type 6.1.4.2. Revenue By Distribution Channel 6.1.4.3. Revenue By Country 6.1.5. 2020 Market Scenario 6.1.6. Quarter by Quarter Forecast 6.1.7. Projected Recovery Quarter 7. Global Rhizoma Gastrodiae Tablets Market Volume (Units) Analysis 2016-2020 and Forecast, 2021-2031 7.1. Historical Market Volume (Units) Analysis, 2016-2020 7.2. Current and Future Market Volume (Units) Projections, 2021-2031 7.2.1. Y-o-Y Growth Trend Analysis 8. Global Rhizoma Gastrodiae Tablets Market - Pricing Analysis 8.1. Regional Pricing Analysis By Type 8.2. Pricing Break-up 8.2.1. Manufacturer Level Pricing 8.2.2. Distributor Level Pricing 8.3. Global Average Pricing Analysis Benchmark 9. Global Rhizoma Gastrodiae Tablets Market Value Analysis 2016–2020 and Forecast, 2021-2031 9.1. Historical Market Value (US$ Mn) Analysis, 2016–2020 9.2. Current and Future Market Value (US$ Mn) Projections, 2021-2031 9.2.1. Y-o-Y Growth Trend Analysis 9.2.2. Absolute $ Opportunity Analysis 10. Global Rhizoma Gastrodiae Tablets Market Analysis 2016–2020 and Forecast 2021-2031, by Type 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Mn) Analysis By Products & Services, 2016–2020 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Type, 2021-2031 10.3.1. GastrodiaElata F. Glauca 10.3.2. G. Elata Bl. F. Elata 10.3.3. Others 10.4. Market Attractiveness Analysis By Type 11. Global Rhizoma Gastrodiae Tablets Market Analysis 2016–2020 and Forecast 2021-2031, by Distribution Channel 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel , 2016–2020 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel , 2021-2031 11.3.1. Hospital Pharmacies 11.3.2. Retail Pharmacies 11.3.3. Online Pharmacies 11.4. Market Attractiveness Analysis By Distribution Channel 12. Global Rhizoma Gastrodiae Tablets Market Analysis 2016–2020 and Forecast 2021-2031, by Region 12.1. Introduction 12.2. Historical Market Size (US$ Mn) Analysis By Region, 2016–2020 12.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2021-2031 12.3.1. North America 12.3.2. Latin America 12.3.3. Europe 12.3.4. East Asia 12.3.5. South Asia 12.3.6. Oceania 12.3.7. Middle East and Africa (MEA) 12.4. Market Attractiveness Analysis By Region 13. North America Rhizoma Gastrodiae Tablets Market Analysis 2016–2020 and Forecast 2021-2031 13.1. Introduction 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020 13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031 13.3.1. By Country 13.3.1.1. U.S. 13.3.1.2. Canada 13.3.2. By Type 13.3.3. By Distribution Channel 13.4. Market Attractiveness Analysis 13.5. Key Market Participants - Intensity Mapping 13.6. Drivers and Restraints - Impact Analysis 14. Latin America Rhizoma Gastrodiae Tablets Market Analysis 2016–2020 and Forecast 2021-2031 14.1. Introduction 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020 14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031 14.3.1. By Country 14.3.1.1. Brazil 14.3.1.2. Mexico 14.3.1.3. Argentina 14.3.1.4. Rest of Latin America 14.3.2. By Type 14.3.3. By Distribution Channel 14.4. Market Attractiveness Analysis 14.5. Key Market Participants - Intensity Mapping 14.6. Drivers and Restraints - Impact Analysis 15. Europe Rhizoma Gastrodiae Tablets Market Analysis 2016–2020 and Forecast 2021-2031 15.1. Introduction 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020 15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031 15.3.1. By Country 15.3.1.1. Germany 15.3.1.2. Italy 15.3.1.3. France 15.3.1.4. U.K. 15.3.1.5. Spain 15.3.1.6. Russia 15.3.1.7. Rest of Europe 15.3.2. By Type 15.3.3. By Distribution Channel 15.4. Market Attractiveness Analysis 15.5. Key Market Participants - Intensity Mapping 15.6. Drivers and Restraints - Impact Analysis 16. South Asia Rhizoma Gastrodiae Tablets Market Analysis 2016–2020 and Forecast 2021-2031 16.1. Introduction 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020 16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031 16.3.1. By Country 16.3.1.1. India 16.3.1.2. Thailand 16.3.1.3. Indonesia 16.3.1.4. Malaysia 16.3.1.5. Rest of South Asia 16.3.2. By Type 16.3.3. By Distribution Channel 16.4. Market Attractiveness Analysis 16.5. Key Market Participants - Intensity Mapping 16.6. Drivers and Restraints - Impact Analysis 17. East Asia Rhizoma Gastrodiae Tablets Market Analysis 2016–2020 and Forecast 2021-2031 17.1. Introduction 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020 17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031 17.3.1. By Country 17.3.1.1. China 17.3.1.2. Japan 17.3.1.3. South Korea 17.3.1.4. Rest of East Asia 17.3.2. By Type 17.3.3. By Distribution Channel 17.4. Market Attractiveness Analysis 17.5. Key Market Participants - Intensity Mapping 17.6. Drivers and Restraints - Impact Analysis 18. Oceania Rhizoma Gastrodiae Tablets Market Analysis 2016–2020 and Forecast 2021-2031 18.1. Introduction 18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020 18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031 18.3.1. By Country 18.3.1.1. Australia 18.3.1.2. New Zealand 18.3.2. By Type 18.3.3. By Distribution Channel 18.4. Market Attractiveness Analysis 18.5. Key Market Participants - Intensity Mapping 18.6. Drivers and Restraints - Impact Analysis 19. Middle East and Africa Rhizoma Gastrodiae Tablets Market Analysis 2016–2020 and Forecast 2021-2031 19.1. Introduction 19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020 19.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031 19.3.1. By Country 19.3.1.1. GCC Countries 19.3.1.2. South Africa 19.3.1.3. Rest of Middle East and Africa 19.3.2. By Type 19.3.3. By Distribution Channel 19.4. Market Attractiveness Analysis 19.5. Drivers and Restraints - Impact Analysis 20. Key and Emerging Countries Rhizoma Gastrodiae Tablets Market Analysis 2016–2020 and Forecast 2021-2031 20.1. Introduction 20.1.1. Market Value Proportion Analysis, By Key Countries 20.1.2. Global Vs. Country Growth Comparison 20.2. U.S. Rhizoma Gastrodiae Tablets Market Analysis 20.2.1. By Type 20.2.2. By Distribution Channel 20.3. Canada Rhizoma Gastrodiae Tablets Market Analysis 20.3.1. By Type 20.3.2. By Distribution Channel 20.4. Mexico Rhizoma Gastrodiae Tablets Market Analysis 20.4.1. By Type 20.4.2. By Distribution Channel 20.5. Brazil Rhizoma Gastrodiae Tablets Market Analysis 20.5.1. By Type 20.5.2. By Distribution Channel 20.6. U.K. Rhizoma Gastrodiae Tablets Market Analysis 20.6.1. By Type 20.6.2. By Distribution Channel 20.7. Germany Rhizoma Gastrodiae Tablets Market Analysis 20.7.1. By Type 20.7.2. By Distribution Channel 20.8. France Rhizoma Gastrodiae Tablets Market Analysis 20.8.1. By Type 20.8.2. By Distribution Channel 20.9. Italy Rhizoma Gastrodiae Tablets Market Analysis 20.9.1. By Type 20.9.2. By Distribution Channel 20.10. Spain Rhizoma Gastrodiae Tablets Market Analysis 20.10.1. By Type 20.10.2. By Distribution Channel 20.11. BENELUX Rhizoma Gastrodiae Tablets Market Analysis 20.11.1. By Type 20.11.2. By Distribution Channel 20.12. Russia Rhizoma Gastrodiae Tablets Market Analysis 20.12.1. By Type 20.12.2. By Distribution Channel 20.13. China Rhizoma Gastrodiae Tablets Market Analysis 20.13.1. By Type 20.13.2. By Distribution Channel 20.14. Japan Rhizoma Gastrodiae Tablets Market Analysis 20.14.1. By Type 20.14.2. By Distribution Channel 20.15. South Korea Rhizoma Gastrodiae Tablets Market Analysis 20.15.1. By Type 20.15.2. By Distribution Channel 20.16. India Rhizoma Gastrodiae Tablets Market Analysis 20.16.1. By Type 20.16.2. By Distribution Channel 20.17. ASEAN Rhizoma Gastrodiae Tablets Market Analysis 20.17.1. By Type 20.17.2. By Distribution Channel 20.18. Australia Rhizoma Gastrodiae Tablets Market Analysis 20.18.1. By Type 20.18.2. By Distribution Channel 20.19. New Zealand Rhizoma Gastrodiae Tablets Market Analysis 20.19.1. By Type 20.19.2. By Distribution Channel 20.20. GCC Countries Rhizoma Gastrodiae Tablets Market Analysis 20.20.1. By Type 20.20.2. By Distribution Channel 20.21. Turkey Rhizoma Gastrodiae Tablets Market Analysis 20.21.1. By Type 20.21.2. By Distribution Channel 20.22. South Africa Rhizoma Gastrodiae Tablets Market Analysis 20.22.1. By Type 20.22.2. By Distribution Channel 21. Market Structure Analysis 21.1. Market Analysis by Tier of Companies 21.2. Market Concentration 21.3. Market Share Analysis of Top Players 21.4. Market Presence Analysis 21.4.1. By Regional footprint of Players 21.4.2. Product foot print by Players 21.4.3. Channel Foot Print by Players 22. Competition Analysis 22.1. Competition Dashboard 22.2. Competition Benchmarking 22.3. Competition Deep dive 22.3.1. ZhaotongHuacheng Pharmaceuticals 22.3.1.1. Overview 22.3.1.2. Product Portfolio 22.3.1.3. Profitability by Market Segments (Product/Channel/Region) 22.3.1.4. Sales Footprint 22.3.1.5. Strategy Overview 22.3.1.5.1. Marketing Strategy 22.3.1.5.2. Product Strategy 22.3.1.5.3. Channel Strategy 22.3.2. Guangdong Luofu Shan National Pharmaceutical Co. Ltd. 22.3.2.1. Overview 22.3.2.2. Product Portfolio 22.3.2.3. Profitability by Market Segments (Product/Channel/Region) 22.3.2.4. Sales Footprint 22.3.2.5. Strategy Overview 22.3.2.5.1. Marketing Strategy 22.3.2.5.2. Product Strategy 22.3.2.5.3. Channel Strategy 22.3.3. Beijing Tong Ren Tang 22.3.3.1. Overview 22.3.3.2. Product Portfolio 22.3.3.3. Profitability by Market Segments (Product/Channel/Region) 22.3.3.4. Sales Footprint 22.3.3.5. Strategy Overview 22.3.3.5.1. Marketing Strategy 22.3.3.5.2. Product Strategy 22.3.3.5.3. Channel Strategy 22.3.4. Guizhou Bailing Group 22.3.4.1. Overview 22.3.4.2. Product Portfolio 22.3.4.3. Profitability by Market Segments (Product/Channel/Region) 22.3.4.4. Sales Footprint 22.3.4.5. Strategy Overview 22.3.4.5.1. Marketing Strategy 22.3.4.5.2. Product Strategy 22.3.4.5.3. Channel Strategy 22.3.5. Guangxi Changzhou Natural Pharmaceutical Co. Ltd. 22.3.5.1. Overview 22.3.5.2. Product Portfolio 22.3.5.3. Profitability by Market Segments (Product/Channel/Region) 22.3.5.4. Sales Footprint 22.3.5.5. Strategy Overview 22.3.5.5.1. Marketing Strategy 22.3.5.5.2. Product Strategy 22.3.5.5.3. Channel Strategy 22.3.6. Lanzhou Foci Pharmaceutical 22.3.6.1. Overview 22.3.6.2. Product Portfolio 22.3.6.3. Profitability by Market Segments (Product/Channel/Region) 22.3.6.4. Sales Footprint 22.3.6.5. Strategy Overview 22.3.6.5.1. Marketing Strategy 22.3.6.5.2. Product Strategy 22.3.6.5.3. Channel Strategy 22.3.7. Shaanxi Tianyang Pharmaceutical 22.3.7.1. Overview 22.3.7.2. Product Portfolio 22.3.7.3. Profitability by Market Segments (Product/Channel/Region) 22.3.7.4. Sales Footprint 22.3.7.5. Strategy Overview 22.3.7.5.1. Marketing Strategy 22.3.7.5.2. Product Strategy 22.3.7.5.3. Channel Strategy 22.3.8. Taiji Group Sichuan Mianyang Pharmaceutical 22.3.8.1. Overview 22.3.8.2. Product Portfolio 22.3.8.3. Profitability by Market Segments (Product/Channel/Region) 22.3.8.4. Sales Footprint 22.3.8.5. Strategy Overview 22.3.8.5.1. Marketing Strategy 22.3.8.5.2. Product Strategy 22.3.8.5.3. Channel Strategy 22.3.9. Tsumura & Co. 22.3.9.1. Overview 22.3.9.2. Product Portfolio 22.3.9.3. Profitability by Market Segments (Product/Channel/Region) 22.3.9.4. Sales Footprint 22.3.9.5. Strategy Overview 22.3.9.5.1. Marketing Strategy 22.3.9.5.2. Product Strategy 22.3.9.5.3. Channel Strategy 23. Assumptions and Acronyms Used 24. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Rhizoma Gastrodiae Tablets Market Volume (‘000 Units) Analysis and Opportunity Assessment 2016–2031, By Type
Table 02: Global Rhizoma Gastrodiae Tablets Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Type
Table 03: Global Rhizoma Gastrodiae Tablets Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Distribution Channel
Table 04: Global Rhizoma Gastrodiae Tablets Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Region
Table 05: North America Rhizoma Gastrodiae Tablets Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country
Table 06: North America Rhizoma Gastrodiae Tablets Market Value (US$ Mn) Analysis and Opportunity Assessment2016–2031, By Type
Table 07: North America Rhizoma Gastrodiae Tablets Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Distribution Channel
Table 08: Latin America Rhizoma Gastrodiae Tablets Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country
Table 09: Latin America Rhizoma Gastrodiae Tablets Market Value (US$ Mn) Analysis and Opportunity Assessment2016–2031, By Type
Table 10: Latin America Rhizoma Gastrodiae Tablets Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Distribution Channel
Table 11: Europe Rhizoma Gastrodiae Tablets Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country
Table 12: Europe Rhizoma Gastrodiae Tablets Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031,By Type
Table 13: Europe Rhizoma Gastrodiae Tablets Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Distribution Channel
Table 14: South Asia Rhizoma Gastrodiae Tablets Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country
Table 15: South Asia Rhizoma Gastrodiae Tablets Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Type
Table 16: South Asia Rhizoma Gastrodiae Tablets Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Distribution Channel
Table 17: East Asia Rhizoma Gastrodiae Tablets Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country
Table 18: East Asia Rhizoma Gastrodiae Tablets Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Type
Table 19: East Asia Rhizoma Gastrodiae Tablets Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Distribution Channel
Table 20: Oceania Rhizoma Gastrodiae Tablets Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country
Table 21: Oceania Rhizoma Gastrodiae Tablets Market Value (US$ Mn) Analysis and Opportunity Assessment2016–2031, By Type
Table 22: Oceania Rhizoma Gastrodiae Tablets Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Distribution Channel
Table 23: Middle East and Africa Rhizoma Gastrodiae Tablets Market Value (US$ Mn) Analysis 2016-2020 and Forecast2021–2031, By Country
Table 24: Middle East and Africa Rhizoma Gastrodiae Tablets Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Type
Table 25: Middle East and Africa Rhizoma Gastrodiae Tablets Market Value (US$ Mn) Analysis and Opportunity Assessment 2016–2031, By Distribution Channel
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Rhizoma Gastrodiae Tablets Market Volume (in 000' Units) Analysis, 2016-2020
Figure 02: Global Rhizoma Gastrodiae Tablets Market Volume Forecast (in 000' Units), 2021-2031
Figure 03: Rhizoma Gastrodiae TabletsPricing Analysis (US$) Per Product, By Region, 2020
Figure 04: Rhizoma Gastrodiae TabletsPricing Analysis (US$) Per Product, By Region, 2020
Figure 05: Global Rhizoma Gastrodiae Tablets Market Value Analysis (US$ Mn), 2016-2020
Figure 06: Global Rhizoma Gastrodiae Tablets Market Value Forecast (US$ Mn), 2021-2031
Figure 07: Global Rhizoma Gastrodiae Tablets Market Absolute $ Opportunity, 2021-2031
Figure 08: Global Rhizoma Gastrodiae Tablets Market Share Analysis (%),By Type, 2021-2031
Figure 09: Global Rhizoma Gastrodiae Tablets Market Y-o-Y Analysis (%), By Type, 2021-2031
Figure 10: Global Rhizoma Gastrodiae Tablets Market Attractiveness Analysis by Type, 2021-2031
Figure 11: Global Rhizoma Gastrodiae Tablets Market Share Analysis (%), By Distribution Channel, 2021-2031
Figure 12: Global Rhizoma Gastrodiae Tablets Market Y-o-Y Analysis (%), By Distribution Channel, 2021-2031
Figure 13: Global Rhizoma Gastrodiae Tablets Market Attractiveness Analysis by Distribution Channel, 2021-2031
Figure 14: Global Rhizoma Gastrodiae Tablets Market Share Analysis (%), By Region, 2021-2031
Figure 15: Global Rhizoma Gastrodiae Tablets Market Y-o-Y Analysis (%), By Region, 2021-2031
Figure 16: Global Rhizoma Gastrodiae Tablets Market Attractiveness Analysis by Region, 2021-2031
Figure 17: North America Rhizoma Gastrodiae Tablets Market Value Share, By Type, 2021 (E)
Figure 18: North America Rhizoma Gastrodiae Tablets Market Value Share, By Distribution Channel, 2021 (E)
Figure 19: North America Rhizoma Gastrodiae Tablets Market Value Share, By Country, 2021 (E)
Figure 20: North America Rhizoma Gastrodiae Tablets Market Value Analysis (US$ Mn), 2016-2020
Figure 21: North America Rhizoma Gastrodiae Tablets Market Value Forecast (US$ Mn), 2021-2031
Figure 22: North America Rhizoma Gastrodiae Tablets Market Attractiveness Analysis by Type, 2021-2031
Figure 23: North America Rhizoma Gastrodiae Tablets Market Attractiveness Analysis by Distribution Channel, 2021-2031
Figure 24: North America Rhizoma Gastrodiae Tablets Market Attractiveness Analysis by Country, 2021-2031
Figure 25: Latin America Rhizoma Gastrodiae Tablets Market Value Share, By Type, 2021 (E)
Figure 26: Latin America Rhizoma Gastrodiae Tablets Market Value Share, By Distribution Channel, 2021 (E)
Figure 27: Latin America Rhizoma Gastrodiae Tablets Market Value Share, By Country, 2021 (E)
Figure 28: Latin America Rhizoma Gastrodiae Tablets Market Value Analysis (US$ Mn), 2016-2020
Figure 29: Latin America Rhizoma Gastrodiae Tablets Market Value Forecast (US$ Mn), 2021-2031
Figure 30: Latin America Rhizoma Gastrodiae Tablets Market Attractiveness Analysis by Type, 2021-2031
Figure 31: Latin America Rhizoma Gastrodiae Tablets Market Attractiveness Analysis by Distribution Channel, 2021-2031
Figure 32: Latin America Rhizoma Gastrodiae Tablets Market Attractiveness Analysis by Country, 2021-2031
Figure 33: Europe Rhizoma Gastrodiae Tablets Market Value Share, By Type, 2021 (E)
Figure 34: Europe Rhizoma Gastrodiae Tablets Market Value Share, By Distribution Channel, 2021 (E)
Figure 35: Europe Rhizoma Gastrodiae Tablets Market Value Share, By Country, 2021 (E)
Figure 36: Europe Rhizoma Gastrodiae Tablets Market Value Analysis (US$ Mn), 2016-2020
Figure 37: Europe Rhizoma Gastrodiae Tablets Market Value Forecast (US$ Mn), 2021-2031
Figure 38: Europe Rhizoma Gastrodiae Tablets Market Attractiveness Analysis by Type,2021-2031
Figure 39: Europe Rhizoma Gastrodiae Tablets Market Attractiveness Analysis by Distribution Channel, 2021-2031
Figure 40: Europe Rhizoma Gastrodiae Tablets Market Attractiveness Analysis by Country, 2021-2031
Figure 41: South Asia Rhizoma Gastrodiae Tablets Market Value Share, By Type, 2021 (E)
Figure 42: South Asia Rhizoma Gastrodiae Tablets Market Value Share, By Distribution Channel, 2021 (E)
Figure 43: South Asia Rhizoma Gastrodiae Tablets Market Value Share, By Country, 2021 (E)
Figure 44: South Asia Rhizoma Gastrodiae Tablets Market Value Analysis (US$ Mn), 2016-2020
Figure 45: South Asia Rhizoma Gastrodiae Tablets Market Value Forecast (US$ Mn), 2021-2031
Figure 46: South Asia Rhizoma Gastrodiae Tablets Market Attractiveness Analysis by Type,2021-2031
Figure 47: South Asia Rhizoma Gastrodiae Tablets Market Attractiveness Analysis by Distribution Channel, 2021-2031
Figure 48: South Asia Rhizoma Gastrodiae Tablets Market Attractiveness Analysis by Country, 2021-2031
Figure 49: East Asia Rhizoma Gastrodiae Tablets Market Value Share, By Type, 2021 (E)
Figure 50: East Asia Rhizoma Gastrodiae Tablets Market Value Share, By Distribution Channel, 2021 (E)
Figure 51: East Asia Rhizoma Gastrodiae Tablets Market Value Share, By Country, 2021 (E)
Figure 52: East Asia Rhizoma Gastrodiae Tablets Market Value Analysis (US$ Mn), 2016-2020
Figure 53: East Asia Rhizoma Gastrodiae Tablets Market Value Forecast (US$ Mn), 2021-2031
Figure 54: East Asia Rhizoma Gastrodiae Tablets Market Attractiveness Analysis by Type,2021-2031
Figure 55: East Asia Rhizoma Gastrodiae Tablets Market Attractiveness Analysis by Distribution Channel, 2021-2031
Figure 56: East Asia Rhizoma Gastrodiae Tablets Market Attractiveness Analysis by Country, 2021-2031
Figure 57: Oceania Rhizoma Gastrodiae Tablets Market Value Share, By Type, 2021 (E)
Figure 58: Oceania Rhizoma Gastrodiae Tablets Market Value Share, By Distribution Channel, 2021 (E)
Figure 59: Oceania Rhizoma Gastrodiae Tablets Market Value Share, By Country, 2021 (E)
Figure 60: Oceania Rhizoma Gastrodiae Tablets Market Value Analysis (US$ Mn), 2016-2020
Figure 61: Oceania Rhizoma Gastrodiae Tablets Market Value Forecast (US$ Mn), 2021-2031
Figure 62: Oceania Rhizoma Gastrodiae Tablets Market Attractiveness Analysis by Type, 2021-2031
Figure 63: Oceania Rhizoma Gastrodiae Tablets Market Attractiveness Analysis by Distribution Channel, 2021-2031
Figure 64: Oceania Rhizoma Gastrodiae Tablets Market Attractiveness Analysis by Country, 2021-2031
Figure 65: Middle East and Africa RhizomaGastrodiae Tablets Market Value Share, By Type, 2021 (E)
Figure 66: Middle East and Africa RhizomaGastrodiae Tablets Market Value Share, By Distribution Channel, 2021 (E)
Figure 67: Middle East and Africa RhizomaGastrodiae Tablets Market Value Share, By Country, 2021 (E)
Figure 68: Middle East and Africa RhizomaGastrodiae Tablets Market Value Analysis (US$ Mn), 2016-2020
Figure 69: Middle East and Africa RhizomaGastrodiae Tablets Market Value Forecast (US$ Mn), 2021-2031
Figure 70: Middle East and Africa RhizomaGastrodiae Tablets Market Attractiveness Analysis by Type,2021-2031
Figure 71: Middle East and Africa RhizomaGastrodiae Tablets Market Attractiveness Analysis by Distribution Channel, 2021-2031
Figure 72: Middle East and Africa RhizomaGastrodiae Tablets Market Attractiveness Analysis by Country, 2021-2031
Figure 73: U. S. Rhizoma Gastrodiae Tablets Market Value Analysis (US$ Mn), 2021 & 2031
Figure 74: U. S. Rhizoma Gastrodiae Tablets Market Value Share, By Type, 2021 (E)
Figure 75: U. S. Rhizoma Gastrodiae Tablets Market Value Share, By Distribution Channel, 2021 (E)
Figure 76: Canada Rhizoma Gastrodiae Tablets Market Value Analysis (US$ Mn), 2021 & 2031
Figure 77: Canada Rhizoma Gastrodiae Tablets Market Value Share, By Type, 2021 (E)
Figure 78: Canada Rhizoma Gastrodiae Tablets Market Value Share, By Distribution Channel, 2021 (E)
Figure 79: Mexico Rhizoma Gastrodiae Tablets Market Value Analysis (US$ Mn), 2021 & 2031
Figure 80: Mexico Rhizoma Gastrodiae Tablets Market Value Share, By Type, 2021 (E)
Figure 81: Mexico Rhizoma Gastrodiae Tablets Market Value Share, By Distribution Channel, 2021 (E)
Figure 82: Brazil Rhizoma Gastrodiae Tablets Market Value Analysis (US$ Mn), 2021 & 2031
Figure 83: Brazil Rhizoma Gastrodiae Tablets Market Value Share, By Type, 2021 (E)
Figure 84: Brazil Rhizoma Gastrodiae Tablets Market Value Share, By Distribution Channel, 2021 (E)
Figure 85: U. K. Rhizoma Gastrodiae Tablets Market Value Analysis (US$ Mn), 2021 & 2031
Figure 86: U. K. Rhizoma Gastrodiae Tablets Market Value Share, By Type, 2021 (E)
Figure 87: U. K. Rhizoma Gastrodiae Tablets Market Value Share, By Distribution Channel, 2021 (E)
Figure 88: Germany Rhizoma Gastrodiae Tablets Market Value Analysis (US$ Mn), 2021 & 2031
Figure 89: Germany Rhizoma Gastrodiae Tablets Market Value Share, By Type, 2021 (E)
Figure 90: Germany Rhizoma Gastrodiae Tablets Market Value Share, By Distribution Channel, 2021 (E)
Figure 91: France Rhizoma Gastrodiae Tablets Market Value Analysis (US$ Mn), 2021 & 2031
Figure 92: France Rhizoma Gastrodiae Tablets Market Value Share, By Type, 2021 (E)
Figure 93: France Rhizoma Gastrodiae Tablets Market Value Share, By Distribution Channel, 2021 (E)
Figure 94: Italy Rhizoma Gastrodiae Tablets Market Value Analysis (US$ Mn), 2021 & 2031
Figure 95: Italy Rhizoma Gastrodiae Tablets Market Value Share, By Type, 2021 (E)
Figure 96: Italy Rhizoma Gastrodiae Tablets Market Value Share, By Distribution Channel, 2021 (E)
Figure 97: Spain Rhizoma Gastrodiae Tablets Market Value Analysis (US$ Mn), 2021 & 2031
Figure 98: Spain Rhizoma Gastrodiae Tablets Market Value Share, By Type, 2021 (E)
Figure 99: Spain Rhizoma Gastrodiae Tablets Market Value Share, By Distribution Channel, 2021 (E)
Figure 100: Russia Rhizoma Gastrodiae Tablets Market Value Analysis (US$ Mn), 2021 & 2031
Figure 101: Russia Rhizoma Gastrodiae Tablets Market Value Share, By Type, 2021 (E)
Figure 102: Russia Rhizoma Gastrodiae Tablets Market Value Share, By Distribution Channel, 2021 (E)
Figure 103: China Rhizoma Gastrodiae Tablets Market Value Analysis (US$ Mn), 2021 & 2031
Figure 104: China Rhizoma Gastrodiae Tablets Market Value Share, By Type, 2021 (E)
Figure 105: China Rhizoma Gastrodiae Tablets Market Value Share, By Distribution Channel, 2021 (E)
Figure 106: Japan Rhizoma Gastrodiae Tablets Market Value Analysis (US$ Mn), 2021 & 2031
Figure 107: Japan Rhizoma Gastrodiae Tablets Market Value Share, By Type, 2021 (E)
Figure 108: Japan Rhizoma Gastrodiae Tablets Market Value Share, By Distribution Channel, 2021 (E)
Figure 109: South Korea Rhizoma Gastrodiae Tablets Market Value Analysis (US$ Mn), 2021 & 2031
Figure 110: South Korea Rhizoma Gastrodiae Tablets Market Value Share, By Type, 2021 (E)
Figure 111: South Korea Rhizoma Gastrodiae Tablets Market Value Share, By Distribution Channel, 2021 (E)
Figure 112: India Rhizoma Gastrodiae Tablets Market Value Analysis (US$ Mn), 2021 & 2031
Figure 113: India Rhizoma Gastrodiae Tablets Market Value Share, By Type, 2021 (E)
Figure 114: India Rhizoma Gastrodiae Tablets Market Value Share, By Distribution Channel, 2021 (E)
Figure 115: ASEAN Rhizoma Gastrodiae Tablets Market Value Analysis (US$ Mn), 2021 & 2031
Figure 116: ASEAN Rhizoma Gastrodiae Tablets Market Value Share, By Type, 2021 (E)
Figure 117: ASEAN Rhizoma Gastrodiae Tablets Market Value Share, By Distribution Channel, 2021 (E)
Figure 118: Australia Rhizoma Gastrodiae Tablets Market Value Analysis (US$ Mn), 2021 & 2031
Figure 119: Australia Rhizoma Gastrodiae Tablets Market Value Share, By Type, 2021 (E)
Figure 120: Australia Rhizoma Gastrodiae Tablets Market Value Share, By Distribution Channel, 2021 (E)
Figure 121: New Zealand Rhizoma Gastrodiae Tablets Market Value Analysis (US$ Mn), 2021 & 2031
Figure 122: New Zealand Rhizoma Gastrodiae Tablets Market Value Share, By Type, 2021 (E)
Figure 123: New Zealand Rhizoma Gastrodiae Tablets Market Value Share, By Distribution Channel, 2021 (E)
Figure 124: GCC Countries Rhizoma Gastrodiae Tablets Market Value Analysis (US$ Mn), 2021 & 2031
Figure 125: GCC Countries Rhizoma Gastrodiae Tablets Market Value Share, By Type, 2021 (E)
Figure 126: GCC Countries Rhizoma Gastrodiae Tablets Market Value Share, By Distribution Channel, 2021 (E)
Figure 127: Turkey Rhizoma Gastrodiae Tablets Market Value Analysis (US$ Mn), 2021 & 2031
Figure 128: Turkey Rhizoma Gastrodiae Tablets Market Value Share, By Type, 2021 (E)
Figure 129: Turkey Rhizoma Gastrodiae Tablets Market Value Share, By Distribution Channel, 2021 (E)
Figure 130: South Africa Rhizoma Gastrodiae Tablets Market Value Analysis (US$ Mn), 2021 & 2031
Figure 131: South Africa Rhizoma Gastrodiae Tablets Market Value Share, By Type, 2021 (E)
Figure 132: South Africa Rhizoma Gastrodiae Tablets Market Value Share, By Distribution Channel, 2021 (E)
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What are the growth prospects for rhizoma gastrodiae tablets market from 2021-2031?
Demand for rhizoma gastrodiae tablets is anticipated to witness a considerable incline from 2021 to 2031 and expand at a CAGR exceeding 10%. Extensive uptake to treat chronic ailments such as liver disorders will greatly
Which country will generate the most promising expansion opportunities for rhizoma gastrodiae tablet manufacturers?
China is likely to emerge as the center-stage for enhanced sales of rhizoma gastrodiae tablets, expected to generate over 50% of total revenue from 2021 to 2031. Simultaneously, India is anticipated to experience a surge of 9% CAGR across the afor
Which type of rhizoma gastrodiae tablets are expected to generate maximum demand through 2031?
Demand for gastrodia elata f. glauca rhizoma gastrodiae tablets to surge at a staggering 10% CAGR over the next ten years.
Rhizoma Gastrodiae Tablets Market